These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 35957871)
1. The IFN-γ-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma. Gu C; Lin C; Zhu Z; Hu L; Wang F; Wang X; Ruan J; Zhao X; Huang S Front Oncol; 2022; 12():955979. PubMed ID: 35957871 [TBL] [Abstract][Full Text] [Related]
2. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y Front Oncol; 2022; 12():876660. PubMed ID: 35747790 [TBL] [Abstract][Full Text] [Related]
3. An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma. Li G; Xu S; Yang S; Wu C; Zhang L; Wang H Front Genet; 2022; 13():1029576. PubMed ID: 36568382 [No Abstract] [Full Text] [Related]
4. Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma. Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H Biomed Res Int; 2022; 2022():2056913. PubMed ID: 35937391 [TBL] [Abstract][Full Text] [Related]
5. Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma. Gao C; Zhou G; Cheng M; Feng L; Cao P; Zhou G Front Genet; 2022; 13():956094. PubMed ID: 36330438 [No Abstract] [Full Text] [Related]
6. Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma. Yao Y; Zhang Q; Wei S; Li H; Zhou T; Zhang Q; Zhang J; Zhang J; Wang H Transl Cancer Res; 2024 Jun; 13(6):2913-2937. PubMed ID: 38988945 [TBL] [Abstract][Full Text] [Related]
7. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
8. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma. Wang T; Ji M; Liu W; Sun J Comput Struct Biotechnol J; 2023; 21():4944-4959. PubMed ID: 37876625 [TBL] [Abstract][Full Text] [Related]
10. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ Front Oncol; 2021; 11():738477. PubMed ID: 34568075 [TBL] [Abstract][Full Text] [Related]
11. A Risk Signature with Nine Stemness Index-Associated Genes for Predicting Survival of Patients with Uterine Corpus Endometrial Carcinoma. Xu H; Zou R; Liu J; Zhu L J Oncol; 2021; 2021():6653247. PubMed ID: 33747079 [TBL] [Abstract][Full Text] [Related]
12. Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature. Ding H; Jiang F; Deng L; Wang J; Wang P; Ji M; Li J; Shi W; Pei Y; Li J; Zhang Y; Zhang Z; Chen Y; Li B Front Cell Dev Biol; 2021; 9():814456. PubMed ID: 35178403 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
15. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C Front Oncol; 2021; 11():640150. PubMed ID: 33869028 [TBL] [Abstract][Full Text] [Related]
16. Disulfidptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Cancer. Shi S; Tang X; Liu H Reprod Sci; 2024 Mar; 31(3):811-822. PubMed ID: 37880552 [TBL] [Abstract][Full Text] [Related]
17. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma. Tang P; Qu W; Wang T; Liu M; Wu D; Tan L; Zhou H Front Genet; 2021; 12():785185. PubMed ID: 34917132 [No Abstract] [Full Text] [Related]
18. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature. Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954 [TBL] [Abstract][Full Text] [Related]
19. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients. He Y; Ye Y; Tian W; Qiu H Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662 [No Abstract] [Full Text] [Related]
20. Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma. Guo C; He Y; Chen L; Li Y; Wang Y; Bao Y; Zeng N; Jiang F; Zhou H; Zhang L Front Oncol; 2022; 12():1030246. PubMed ID: 36439473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]